| Title |
Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study
|
|---|---|
| Published in |
BioDrugs, October 2018
|
| DOI | 10.1007/s40259-018-0313-2 |
| Pubmed ID | |
| Authors |
Cristina Scavone, Maurizio Sessa, Emilio Clementi, Giovanni Corrao, Roberto Leone, Alessandro Mugelli, Francesco Rossi, Edoardo Spina, Annalisa Capuano |
Mendeley readers
The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 40 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 5 | 13% |
| Student > Ph. D. Student | 4 | 10% |
| Student > Master | 4 | 10% |
| Other | 3 | 8% |
| Student > Postgraduate | 3 | 8% |
| Other | 4 | 10% |
| Unknown | 17 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 18% |
| Medicine and Dentistry | 6 | 15% |
| Nursing and Health Professions | 2 | 5% |
| Social Sciences | 2 | 5% |
| Mathematics | 1 | 3% |
| Other | 5 | 13% |
| Unknown | 17 | 43% |